4.7 Article

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Genetics & Heredity

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

Andrew R. Harper et al.

Summary: The study identified 12 genome-wide significant susceptibility loci for HCM, showing a strong polygenic influence, especially for sarcomere-negative HCM. A genetic risk score influenced the odds of HCM and phenotypic severity in carriers of sarcomere variants. Mendelian randomization identified diastolic blood pressure as a key modifiable risk factor for sarcomere-negative HCM.

NATURE GENETICS (2021)

Article Genetics & Heredity

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

Rafik Tadros et al.

Summary: The study found a strong genetic correlation between hypertrophic and dilated cardiomyopathies and left ventricular traits, with opposing genetic effects in the two cardiomyopathies. The research also supported a causal association between increased left ventricular contractility and hypertrophic cardiomyopathy risk.

NATURE GENETICS (2021)

Article Cardiac & Cardiovascular Systems

Clinical Profile and Health Disparities in a Multiethnic Cohort of Patients With Hypertrophic Cardiomyopathy

Alexandra Butters et al.

Summary: A study on a multiethnic Australian hypertrophic cardiomyopathy population revealed some clinical differences among different ethnic groups, particularly in access to genetic testing and implantable cardioverter-defibrillator use.

CIRCULATION-HEART FAILURE (2021)

Letter Cardiac & Cardiovascular Systems

A Pathogenic Variant in ALPK3 Is Associated With an Autosomal Dominant Adult-onset Hypertrophic Cardiomyopathy

Chanatjit Cheawsamoot et al.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2020)

Article Biochemistry & Molecular Biology

Prevalence of TTR variants detected by whole-exome sequencing in hypertrophic cardiomyopathy

Luis R. Lopes et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2019)

Article Cardiac & Cardiovascular Systems

Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry

Stefan Neubauer et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

Jodie Ingles et al.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

Juan Pablo Ochoa et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Biochemistry & Molecular Biology

The ExAC browser: displaying reference data information from over 60 000 exomes

Konrad J. Karczewski et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Medicine, Research & Experimental

ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features

Ahmet Okay Caglayan et al.

COLD SPRING HARBOR MOLECULAR CASE STUDIES (2017)

Article Cardiac & Cardiovascular Systems

Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy

Rowida Almomani et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Constantinos O'Mahony et al.

EUROPEAN HEART JOURNAL (2014)

Article Genetics & Heredity

A general approach to power calculation for relationship testing

Thore Egeland et al.

FORENSIC SCIENCE INTERNATIONAL-GENETICS (2014)

Article Pathology

Cardiomyopathy in alpha-Kinase 3 (ALPK3)-Deficient Mice

I. Van Sligtenhorst et al.

VETERINARY PATHOLOGY (2012)

Article Biochemistry & Molecular Biology

A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes

T Hosoda et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)